Previous Close | 82.34 |
1-Year Change | 52.31% |
6-Months Change | 53.91% |
3-Months Change | 34.81% |
Moving Avg (50d) | 67.127 |
Moving Avg (200d) | 61.169 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 18.5B |
Beta (3-Years) | 0.51 |
Revenue Growth (ttm) | 8.35% |
Net Profit Margin (ttm) | 11.78% |
Return On Assets (ttm) | 6.65% |
EPS (ttm) | 1.88 |
PE Ratio (ttm) | 43.8 |
Dividend Yield | % |
Asset Description: | Incyte Corporation |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2024-10-29 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
80.693 | 78.223 | 76.576 | 74.106 | 69.989 | 65.872 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.